Aging Stereotypes and Prodromal Alzheimer's Disease
Launched by ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE · Apr 28, 2017
Trial Information
Current as of July 06, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients must be at least 50 years old
- • Patients must report memory complaints
- • Patients must show signs of MCI (amnestic single or multiple domain) on the following short cognitive tests
- Exclusion Criteria:
- • Probable Alzheimer's Disease according to NINCDS-ADRDA criteria (MA patients will be excluded from the study because false-positive errors only concern MCI status, not AD)
- • Psychiatric disorders (schizophrenia, bipolar disorder)
- • Cranial trauma
- • Developmental pathologies
- • Depression (score greater than or equal to 10 on GDS)
- • Psychotropic medication if modified in the last 3 months
About Assistance Publique Hopitaux De Marseille
Assistance Publique - Hôpitaux de Marseille (AP-HM) is a leading public healthcare institution in France, dedicated to providing high-quality medical care and advancing research in various clinical fields. As a prominent sponsor of clinical trials, AP-HM is committed to fostering innovation and improving patient outcomes through rigorous scientific investigation. With a multidisciplinary approach, the institution collaborates with a network of healthcare professionals, researchers, and academic partners to facilitate cutting-edge studies that address critical health challenges. AP-HM's dedication to ethical standards and patient safety underscores its role as a trusted leader in clinical research and healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, , France
Patients applied
Trial Officials
Urielle DESALBRES, Director
Study Director
ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials